Editorial Article: T Cell Engineering for Breakthrough Immunotherapy Research – SelectScience
SelectScience |
Editorial Article: T Cell Engineering for Breakthrough Immunotherapy Research
SelectScience The adoptive transfer of T cells expressing genetically engineered chimeric antigen receptors (CARs) has shown great potential in the treatment of certain leukemias. In CAR T therapy, T cells are removed from the patient and modified to express … |
